frog is a leading global creative consultancy, part of Capgemini Invent. We challenge the status quo to craft and build transformative human experiences that win hearts and move markets.

London, United Kingdom
Organisational Design
Insight-Driven Marketing
Marketing Strategy
Campaign Management
Innovation Strategy
Customer Intelligence
Customer Experience
Relationship Marketing

and 1 more

Johnson & Johnson
Scottish Water
National Grid
Talk Talk
cathay pacific

and 11 more

Sector Experience

Consumer Products, Retail & Distribution
Energy, Utilities & Chemicals
Financial Services (Insurance & Banking)
Public Sector
Manufacturing, Automotive and Life Sciences
Telecommunications, Media and Entertainment
Travel & Transport

Defining the strategy required to deliver a consumer obsessed insights ecosystem

by Ellie Huggins

The Brief

The Global Pharma Company had an ambition to redefine its Insights and Analytics ecosystem to make the company “Human Obsessed”, including which services it should deliver to the business, what data sources and insight products will be of highest value and what technology and capabilities will be required. The client needed a roadmap of prioritized steps to get there with a set of well-defined short-term wins and strategic longer term wins with a focus on output that drives impact.​

The Solution

Capgemini, alongside our partner agency Freemavens, worked in a unique dual-agency model with the Global Pharma Company's insights function to develop 15 insight product concepts. These concepts built on innovative insight generations techniques such as social listening, search, semiotics and a set of deliverables informing the recommended strategy to deliver them, including a multi-year transformation roadmap, capability design, location strategy and data & tech requirements, alongside the associated business plan and investment needed to operationalize them. These products will allow them to expand their reach beyond traditional addressed functions such as marketing, catering to requirements from other functions such as digital, media, supply chain, R&D, PR, HR, Legal, Commercial Excellence and will be deployed globally across a set of markets initially followed by a full global rollout.

The Results

The Global Pharma Company approved a set of priorities to take into the first major phase of the project, along with a recommended list of vendors. Five products were identified to be implemented first across a set of representative markets, alongside seven key capabilities to be operationalized through new ways of working.